Entering text into the input field will update the search result below

Regulus perks up 20% on Chairman's stock purchase

  • Nano cap Regulus Therapeutics (RGLS +20%) is up on average volume. The jump in buying is being stoked by the disclosure that Chairman Stelios Papadopoulos recently acquired a 500K stake at an average price of ~$1.22.
  • The company's pipeline consists of HCV candidate RG-101, Alport syndrome candidate RG-012, diabetes candidate RG-125 and kidney disease candidate RGLS4326.

Recommended For You

About RGLS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
RGLS--
Regulus Therapeutics Inc.